Valneva SE VALN
NASDAQ VALN
$6.14 -0.33 (-5.10%)
At close: Sep 29, 2026 · 4:00 PM EDT

Valneva SE (VALN) Common Equity (2019 - 2026)

Updated

Valneva SE (VALN) posted Common Equity of $94.29 million for Q2 2026, down 55.3% from $211.03 million a year earlier but up 5.0% from the prior quarter.

Analysis

Valneva SE (VALN) Common Equity (2019 - 2026) Analysis & Trends

At the end of FY2025, Valneva SE's Common Equity came in at $119.95 million, down 38.1% from FY2024.

  • Annual Common Equity shows a five-year compound annual growth rate of 6.3% (FY2020 to FY2025).
  • In prior years, Valneva SE's Common Equity was $193.69 million in FY2024 (+40.4%), $137.99 million in FY2023 (-38.5%), $224.25 million in FY2022 and $18.68 million in FY2021 (-78.9%).
  • Quarterly Common Equity has run from a low of $17.75 million in Q3 2022 to a high of $238.83 million in Q3 2024 over five years.
  • On a year-over-year basis, Common Equity has declined in each of the last four quarters, with an average decline of 10.2% over the last eight quarters.
  • The strongest year-over-year quarter for Common Equity in the past five years was Q3 2023, with growth of 866.1%; the weakest was Q4 2021, with a decline of 80.4%.
  • According to Business Quant data, Common Equity for the three prior quarters was $89.8 million (Q1 2026), $123.58 million (Q4 2025) and $175.92 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 84.97 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -5.94 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 50.37 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 20.25 Bn
10 Valneva SE 561.40 Mn 1.51 Mn 1.86 Mn 94.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 94.29 Mn
Mar 31, 2026 89.80 Mn
Dec 31, 2025 123.58 Mn
Sep 30, 2025 175.92 Mn
Jun 30, 2025 211.03 Mn
Mar 31, 2025 184.35 Mn
Dec 31, 2024 193.69 Mn
Sep 30, 2024 238.83 Mn
Jun 30, 2024 179.06 Mn
Mar 31, 2024 205.57 Mn
Dec 31, 2023 137.99 Mn
Sep 30, 2023 171.48 Mn
Jun 30, 2023 207.67 Mn
Mar 31, 2023 219.80 Mn
Dec 31, 2022 224.25 Mn
Sep 30, 2022 17.75 Mn
Jun 30, 2022 18.78 Mn
Mar 31, 2022 166.56 Mn
Dec 31, 2021 18.06 Mn
Jun 30, 2021 92.81 Mn
API Access

Valneva SE Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=VALN&period=max&api_key=YOUR_API_KEY